Major histocompatibility complex genomics and human disease

Annual Review of Genomics and Human Genetics

Volumn 14, Issue , 2013, Pages 301-323

  Trowsdale, John ^a   Knight, Julian C ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antigen presentation; Antigen processing; HLA; Imputation; MHC; Polymorphism

Indexed keywords

COMPLEMENT COMPONENT C4; FC RECEPTOR; HLA A2 ANTIGEN; HLA ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICRORNA; STEROID 21 MONOOXYGENASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; ALLOTYPE; AMINO ACID SEQUENCE; ANKYLOSING SPONDYLITIS; ANTIGEN PRESENTATION; AUTOIMMUNITY; BINDING SITE; CELIAC DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME DUPLICATION; CONGENITAL ADRENAL HYPERPLASIA; CROSS PRESENTATION; DENGUE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA FLANKING REGION; DNA METHYLATION; DNA SEQUENCE; EHLERS DANLOS SYNDROME; ENDOPLASMIC RETICULUM; EPIGENETICS; GENE CONVERSION; GENE DUPLICATION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC VARIABILITY; GENOMIC FRAGMENT; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; GRAVES DISEASE; HAPLOTYPE; HEAVY CHAIN; HIGH THROUGHPUT SEQUENCING; HLA TYPING; HODGKIN DISEASE; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOVOLEMIC SHOCK; IMMUNE RESPONSE; IMMUNOGLOBULIN A DEFICIENCY; INFECTION RESISTANCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALARIA; MEDICAL HISTORY; METHYLATION; MOLECULAR RECOGNITION; MONOCYTE; MONOTREMATE; MUCOLIPIDOSIS TYPE 1; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; MYOCLONUS EPILEPSY; NARCOLEPSY; NASOPHARYNX CARCINOMA; NATURAL KILLER CELL; NATURAL SELECTION; NERVE CELL PLASTICITY; NONHUMAN; PARKINSON DISEASE; PEMPHIGUS VULGARIS; PLACENTAL MAMMALS; POINT MUTATION; POPULATION MIGRATION; PROTEIN EXPRESSION; PSEUDOGENE; PSORIASIS; QUANTITATIVE TRAIT LOCUS; REVIEW; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS;

ANIMALS; BIOLOGICAL EVOLUTION; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84884311983     PISSN: 15278204     EISSN: 1545293X     Source Type: Book Series    
DOI: 10.1146/annurev-genom-091212-153455     Document Type: Review

References (136)

1. Abi-Rached L, Gilles A, Shiina T, Pontarotti P, Inoko H. 2002. Evidence of en bloc duplication in vertebrate genomes. Nat. Genet. 31:100-5
2. Abi-Rached L, Jobin MJ, Kulkarni S, McWhinnie A, Dalva K, et al. 2011. The shaping of modern human immune systems by multiregional admixture with archaic humans. Science 334:89-94
3. Abi-Rached L, McDermott MF, Pontarotti P. 1999. The MHC big bang. Immunol. Rev. 167:33-44
4. Achkar JP, Klei L, Bakker PI, Bellone G, Rebert N, et al. 2012. Amino acid position 11 of HLA-DRβ1 is a major determinant of chromosome 6p association with ulcerative colitis. Genes Immun. 13:245-52
5. Agrawal A, Eastman QM, Schatz DG. 1998. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 394:744-51
6. Apps R, Qi Y, Carlson JM, Chen H, Gao X, et al. 2013. Influence of HLA-C expression level on HIV control. Science 340:87-91
7. Barrow AD, Trowsdale J. 2008. The extended human leukocyte receptor complex: Diverse ways of modulating immune responses. Immunol. Rev. 224:98-123
8. Basha G, Omilusik K, Chavez-Steenbock A, Reinicke AT, Lack N, et al. 2012. ACD74-DependentMHC class I endolysosomal cross-presentation pathway. Nat. Immunol. 13:237-45
9. Belov K. 2012. Contagious cancer: Lessons from the devil and the dog. BioEssays 34:285-92
10. Belov K, Deakin JE, Papenfuss AT, Baker ML, Melman SD, et al. 2006. Reconstructing an ancestral mammalian immune supercomplex from a marsupial major histocompatibility complex. PLoS Biol. 4:e46
11. Bentley G, Higuchi R, Hoglund B, Goodridge D, Sayer D, et al. 2009. High-resolutio n, high-Throughput HLA genotyping by next-generation sequencing. Tissue Antigens 74:393-403
12. Bharadwaj M, Illing P, Theodossis A, Purcell AW, Rossjohn J, McCluskey J. 2012. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex. Annu. Rev. Pharmacol. Toxicol. 52:401-31
13. Bowerman NA, FaltaM T, MackD G, Kappler JW, FontenotAP. 2011. Mutagenesis of beryllium-specific TCRs suggests an unusual binding topology for antigen recognition. J. Immunol. 187:3694-703
14. Braunstein NS, Germain RN, Loney K, Berkowitz N. 1990. Structurally interdependent and independent regions of allelic polymorphism in class II MHC molecules. Implications for Ia function and evolution. J. Immunol. 145:1635-45
15. Brown D, Trowsdale J, Allen R. 2004. The LILR family: Modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64:215-25
16. Carlson JM, Listgarten J, Pfeifer N, Tan V, Kadie C, et al. 2012. Widespread impact of HLA restriction on immune control and escape pathways of HIV-1. J. Virol. 86:5230-43
17. Castro LF, Furlong RF, Holland PW. 2004. An antecedent of the MHC-linked genomic region in amphioxus. Immunogenetics 55:782-84
18. Castro-Prieto A, Wachter B, Sommer S. 2011. Cheetah paradigm revisited:MHCdiversity in theworld's largest free-ranging population. Mol. Biol. Evol. 28:1455-68
19. Chabas D, Taheri S, Renier C, Mignot E. 2003. The genetics of narcolepsy. Annu. Rev. Genomics Hum. Genet. 4:459-83
20. Chao MJ, Barnardo MC, Lincoln MR, Ramagopalan SV, Herrera BM, et al. 2008. HLA class I alleles tag HLA-DRB1. 1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc. Natl. Acad. Sci. USA 105:13069-74
21. Chazara O, Xiong S, Moffett A. 2011. Maternal KIR and fetal HLA-C: A fine balance. J. Leukoc. Biol. 90:703-16
22. Dai S, Murphy GA, Crawford F, Mack DG, Falta MT, et al. 2010. Crystal structure of HLA-DP2 and implications for chronic beryllium disease. Proc. Natl. Acad. Sci. USA 107:7425-30
23. Danchin EG, Pontarotti P. 2004. Towards the reconstruction of the bilaterian ancestral pre-MHC region. Trends Genet. 20:587-91
24. Davies RW, Wells GA, Stewart AF, Erdmann J, Shah SH, et al. 2012. A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in themajor histocompatibility complex. Circ. Cardiovasc. Genet. 5:217-25
25. Dawkins R, Leelayuwat C, Gaudieri S, Tay G, Hui J, et al. 1999. Genomics of the major histocompatibility complex: Haplotype s, duplicatio n, retroviruses and disease. Immunol. Rev. 167:275-304
26. De Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, et al. 2006. A high-resolution HLA and SNP haplotypemap for disease association studies in the extended human MHC. Nat. Genet. 38:1166-72
27. Delarbre C, Jaulin C, Kourilsky P, Gachelin G. 1992. Evolution of the major histocompatibility complex: A hundred-fold amplification of MHC class I genes in the African pigmy mouse Nannomys setulosus. Immunogenetics 37:29-38
28. De La Salle H, Hanau D, Fricker D, Urlacher A, Kelly A, et al. 1994. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265:237-41
29. Dilthey AT, Moutsianas L, Leslie S, McVean G. 2011. HLA. IMP-An integrated framework for imputing classical HLA alleles from SNP genotypes. Bioinformatics 27:968-72
30. ENCODE Proj. Consort. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489:57-74
31. Erlich RL, Jia X, Anderson S, Banks E, Gao X, et al. 2011. Next-generation sequencing for HLA typing of class I loci. BMC Genomics 12:42
32. EvansD M, Spencer CC, Pointon JJ, Su Z, Harvey D, et al. 2011. Interaction between ERAP1 andHLAB27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat. Genet. 43:761-67
33. Evseeva I, Nicodemus KK, Bonilla C, Tonks S, Bodmer WF. 2010. Linkage disequilibrium and age of HLA region SNPs in relation to classic HLA gene alleles within Europe. Eur. J. Hum. Genet. 18:924-32
34. Fadda L, Borhis G, Ahmed P, Cheent K, Pageon SV, et al. 2010. Peptide antagonism as a mechanism for NK cell activation. Proc. Natl. Acad. Sci. USA 107:10160-65
35. Fairfax BP, Makino S, Radhakrishnan J, Plant K, Leslie S, et al. 2012. Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles ofHLA alleles. Nat. Genet. 44:502-10
36. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, et al. 1996. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13:399-408
37. Fehrmann RS, Jansen RC, Veldink JH, Westra HJ, Arends D, et al. 2011. Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate gene s, with a major role for the HLA. PLoS Genet. 7:e1002197
38. Ferreira RC, Pan-Hammarstrom Q, Graham RR, Fontan G, Lee AT, et al. 2012. High-Density SNP mapping of the HLA region identifies multiple independent susceptibility loci associated with selective IgA deficiency. PLoS Genet. 8:e1002476
39. FlajnikM F, Canel C, Kramer J, KasaharaM. 1991. Which came firs t, MHC class I or class II? Immunogenetics 33:295-300
40. Fust G, Arason GJ, Kramer J, Szalai C, Duba J, et al. 2004. Genetic basis of tobacco smoking: Strong association of a specific major histocompatibility complex haplotype on chromosome 6 with smoking behavior. Int. Immunol. 16:1507-14
41. Gabriel C, Danzer M, Hackl C, Kopal G, Hufnagl P, et al. 2009. Rapid high-Throughput human leukocyte antigen typing by massively parallel pyrosequencing for high-resolution allele identification. Hum. Immunol. 70:960-64
42. Gaudieri S, Leelayuwat C, Tay GK, Townend DC, Dawkins RL. 1997. The major histocompatability complex (MHC) contains conserved polymorphic genomic sequences that are shuffled by recombination to form ethnic-specific haplotypes. J. Mol. Evol. 45:17-23
43. HamzaT H, Zabetian CP, Tenesa A, Laederach A, Montimurro J, et al. 2010. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat. Genet. 42:781-85
44. Handunnetthi L, Ramagopalan SV, Ebers GC. 2010. Multiple sclerosi s, vitamin D, and HLA-DRB1 15. Neurology 74:1905-10
45. Harari A, Cellerai C, Enders FB, Kostler J, Codarri L, et al. 2007. Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Proc. Natl. Acad. Sci. USA 104:16233-38
46. Havlicek J, Roberts SC. 2009. MHC-correlated mate choice in humans: A review. Psychoneuroendocrinology 34:497-512
47. Hiby SE, Apps R, Sharkey AM, Farrell LE, Gardner L, et al. 2010. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J. Clin. Investig. 120:4102-10
48. Hill-Burns EM, Factor SA, Zabetian CP, Thomson G, Payami H. 2011. Evidence for more than one Parkinson's disease-Associated variant within the HLA region. PLoS ONE 6:e27109
49. Hirayasu K, Ohashi J, Kashiwase K, Hananantachai H, Naka I, et al. 2012. Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA. PLoS Pathog. 8:e1002565
50. Holcomb CL, Hoglund B, Anderson MW, Blake LA, Bohme I, et al. 2011. A multi-site study using high-resolution HLA genotyping by next generation sequencing. Tissue Antigens 77:206-17
51. Horton R, Gibson R, Coggill P, Miretti M, Allcock RJ, et al. 2008. Variation analysis and gene annotation of eight MHC haplotypes: The MHC Haplotype Project. Immunogenetics 60:1-18
52. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, et al. 2004. Gene map of the extended human MHC. Nat. Rev. Genet. 5:889-99
53. Huang J, Al-Mozaini M, Rogich J, Carrington MF, Seiss K, et al. 2012. Systemic inhibition of myeloid dendritic cells by circulating HLA class I molecules in HIV-1 infection. Retrovirology 9:11
54. Huang J, Burke PS, Cung TD, Pereyra F, Toth I, et al. 2010. Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers. J. Virol. 84:9463-71
55. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, et al. 2004. Detection of large-scale variation in the human genome. Nat. Genet. 36:949-51
56. Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, et al. 2012. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 486:554-58
57. Jacob CO, McDevitt HO. 1988. Tumour necrosis factor-A in murine autoimmune lupus nephritis. Nature 331:356-58
58. Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, et al. 2000. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J. Immunol. 165:7278-84
59. Karre K, Ljunggren HG, Piontek G, Kiessling R. 1986. Selective rejection of H-2-Deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675-78
60. Karttunen JT, Trowsdale J, Lehner PJ. 1999. Antigen presentation: TAP dances with ATP. Curr. Biol. 9:R820-24
61. Kasahara M. 1999. The chromosomal duplication model of the major histocompatibility complex. Immunol. Rev. 167:17-32
62. Kaufman J. 2000. The simple chicken major histocompatibility complex: Life and death in the face of pathogens and vaccines. Philos. Trans. R. Soc. Lond. B 355:1077-84
63. Kaufman J, Milne S, Gobel TW, Walker BA, Jacob JP, et al. 1999. The chicken B locus is a minimal essential major histocompatibility complex. Nature 401:923-25
64. Kelley J, Walter L, Trowsdale J. 2005. Comparative genomics of major histocompatibility complexes. Immunogenetics 56:683-95
65. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, et al. 2002. The human genome browser at UCSC. Genome Res. 12:996-1006
66. Khor CC, Chau TN, Pang J, Davila S, Long HT, et al. 2011. Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat. Genet. 43:1139-41
67. Kincaid EZ, Che JW, York I, Escobar H, Reyes-Vargas E, et al. 2012. Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat. Immunol. 13:129-35
68. Klein J. 1986. Natural History of the Major Histocompatibility Complex. New York:Wiley
69. Ko TM, Chung WH, Wei CY, ShihH Y, Chen JK, et al. 2011. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome. J. Allergy Clin. Immunol. 128:1266-76 e11
70. Kong A, Thorleifsson G, Gudbjartsson DF, Masson G, Sigurdsson A, et al. 2010. Fine-scale recombination rate differences between sexe s, populations and individuals. Nature 467:1099-103
71. Kraman M, Bambrough PJ, Arnold JN, Roberts EW, Magiera L, et al. 2010. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-A. Science 330:827-30
72. Kulkarni S, Savan R, Qi Y, Gao X, Yuki Y, et al. 2011. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472:495-98
73. Kulpa DA, Collins KL. 2011. The emerging role ofHLA-C in HIV-1 infection. Immunology 134:116-22
74. Lederberg J. 1999. J. B. S. Haldane (1949) on infectious disease and evolution. Genetics 153:1-3
75. Leslie S, Donnelly P, McVean G. 2008. A statistical method for predicting classical HLA alleles from SNP data. Am. J. Hum. Genet. 82:48-56
76. Lichterfeld M, Yu XG. 2012. The emerging role of leukocyte immunoglobulin-like receptors (LILRs) in HIV-1 infection. J. Leukoc. Biol. 91:27-33
77. Lind C, Ferriola D, Mackiewicz K, Heron S, Rogers M, et al. 2010. Next-generation sequencing: The solution for high-resolutio n, unambiguous human leukocyte antigen typing. Hum. Immunol. 71:1033-42
78. Makrigiannis AP, Parham P. 2008. The evolution of NK cell diversity. Semin. Immunol. 20:309-10
79. Malkki M, Single R, Carrington M, Thomson G, Petersdorf E. 2005. MHC microsatellite diversity and linkage disequilibrium among common HLA-A, HLA-B, DRB1 haplotypes: Implications for unrelated donor hematopoietic transplantation and disease association studies. Tissue Antigens 66:114-24
80. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, et al. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39:733-40
81. Maruoka T, Tanabe H, Chiba M, Kasahara M. 2005. Chicken CD1 genes are located in the MHC: CD1 and endothelial protein C receptor genes constitute a distinct subfamily of class-I-like genes that predates the emergence of mammals. Immunogenetics 57:590-600
82. McDevitt H. 2002. The discovery of linkage between the MHC and genetic control of the immune response. Immunol. Rev. 185:78-85
83. McMichael AJ, Jones EY. 2010. First-class control of HIV-1. Science 330:1488-90
84. MehtaN T, Truax AD, Boyd NH, Greer SF. 2011. Early epigenetic events regulate the adaptive immune response gene CIITA. Epigenetics 6:516-25
85. MHC Seq. Consort. 1999. Complete sequence and gene map of a human major histocompatibility complex. Nature 401:921-23
86. Mignot E, Kimura A, Lattermann A, Lin X, Yasunaga S, et al. 1997. Extensive HLA class II studies in 58 non-DRB1. 15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens 49:329-41
87. Miretti MM, Walsh EC, Ke X, Delgado M, Griffiths M, et al. 2005. A high-resolution linkagedisequilibrium map of the human major histocompatibility complex and first generation of tag singlenucleotide polymorphisms. Am. J. Hum. Genet. 76:634-46
88. MooreC B, John M, James IR, Christiansen FT, Witt CS, Mallal SA. 2002. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296:1439-43
89. Nathenson SG, Geliebter J, Pfaffenbach GM, Zeff RA. 1986. Murine major histocompatibility complex class-I mutants: Molecular analysis and structure-function implications. Annu. Rev. Immunol. 4:471-502
90. Norman PJ, Abi-Rached L, Gendzekhadze K, Hammond JA, Moesta AK, et al. 2009. Meiotic recombination generates rich diversity in NK cell receptor gene s, allele s, and haplotypes. Genome Res. 19:757-69
91. Ohta Y, Shiina T, Lohr RL, Hosomichi K, Pollin TI, et al. 2011. Primordial linkage of β2-microglobulin to the MHC. J. Immunol. 186:3563-71
92. Parham P, Ohta T. 1996. Population biology of antigen presentation byMHC class I molecules. Science 272:67-74
93. Powis SJ, Deverson EV, Coadwell WJ, Ciruela A, Huskisson NS, et al. 1992. Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature 357:211-15
94. Price P, Witt C, Allcock R, Sayer D, Garlepp M, et al. 1999. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol. Rev. 167:257-74
95. Pr öll J, Danzer M, Stabentheiner S, Niklas N, Hackl C, et al. 2011. Sequence capture and next generation resequencing of the MHC region highlights potential transplantation determinants in HLA identical haematopoietic stem cell transplantation. DNA Res. 18:201-10
96. Prugnolle F, Manica A, Charpentier M, Guegan JF, Guernier V, Balloux F. 2005. Pathogen-Driven selection and worldwide HLA class I diversity. Curr. Biol. 15:1022-27
97. Qidwai T, Khan F. 2011. Tumour necrosis factor gene polymorphism and disease prevalence. Scand. J. Immunol. 74:522-47
98. Rajapaksa US, Li D, Peng YC, McMichael AJ, Dong T, Xu XN. 2012. HLA-B may be more protective against HIV-1 thanHLA-A because it resists negative regulatory factor (Nef )mediated down-regulation. Proc. Natl. Acad. Sci. USA 109:13353-58
99. Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, et al. 2009. Expression of the multiple sclerosis-Associated MHC class II allele HLA-DRB1. 1501 is regulated by vitamin D. PLoS Genet. 5:e1000369
100. Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, et al. 2012. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 44:291-96
101. Raymond CK, Kas A, Paddock M, Qiu R, Zhou Y, et al. 2005. Ancient haplotypes of the HLA Class II region. Genome Res. 15:1250-57
102. Reusch TB, Haberli MA, Aeschlimann PB, Milinski M. 2001. Female sticklebacks count alleles in a strategy of sexual selection explaining MHC polymorphism. Nature 414:300-2
103. Robinson J, Mistry K, McWilliam H, Lopez R, Parham P, Marsh SG. 2011. The IMGT/HLA database. Nucleic Acids Res. 39:D1171-76
104. Romagnoli P, Spinas GA, Sinigaglia F. 1992. Gold-specificTcells in rheumatoid arthritis patients treated with gold. J. Clin. Investig. 89:254-58
105. Santos PS, Fust G, Prohaszka Z, Volz A, Horton R, et al. 2008. Association of smoking behavior with an odorant receptor allele telomeric to the humanmajor histocompatibility complex. Genet. Test. 12:481-86
106. Shatz CJ. 2009. MHC class I: An unexpected role in neuronal plasticity. Neuron 64:40-45
107. Shiina T, Ota M, Shimizu S, Katsuyama Y, Hashimoto N, et al. 2006. Rapid evolution of major histocompatibility complex class I genes in primates generates new disease alleles in humans via hitchhiking diversity. Genetics 173:1555-70
108. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, et al. 2005. Evolutionarily conserved elements in vertebrat e, insec t, wor m, and yeast genomes. Genome Res. 15:1034-50
109. Single RM, Martin MP, Gao X, Meyer D, Yeager M, et al. 2007. Global diversity and evidence for coevolution of KIR and HLA. Nat. Genet. 39:1114-19
110. Star B, Nederbragt AJ, Jentoft S, Grimholt U, Malmstrom M, et al. 2011. The genome sequence of Atlantic cod reveals a unique immune system. Nature 477:207-10
111. Steimle V, Otten LA, Zufferey M, Mach B. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditaryMHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135-46
112. Stewart CA, Horton R, Allcock RJ, Ashurst JL, Atrazhev AM, et al. 2004. Complete MHC haplotype sequencing for common disease gene mapping. Genome Res. 14:1176-87
113. Strange A, Capon F, Spencer CC, Knight J, Weale ME, et al. 2010. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 42:985-90
114. Suemizu H, Radosavljevic M, Kimura M, Sadahiro S, Yoshimura S, et al. 2002. A basolateral sorting motif in the MICA cytoplasmic tail. Proc. Natl. Acad. Sci. USA 99:2971-76
115. Todd JA, Bell JI, McDevitt HO. 1987. HLA-DQβ gene contributes to susceptibility and resistance to insulin-Dependent diabetes mellitus. Nature 329:599-604
116. Tomazou EM, Rakyan VK, Lefebvre G, Andrews R, Ellis P, et al. 2008. Generation of a genomic tiling array of the human major histocompatibility complex (MHC) and its application for DNA methylation analysis. BMC Med. Genomics 1:19
117. Torres AR, Maciulis A, OdellD. 2001. The association ofMHCgenes with autism. Front. Biosci. 6:D936-43
118. Traherne JA, Horton R, RobertsA N, MirettiM M, Hurles ME, et al. 2006. Genetic analysis of completely sequenced disease-Associated MHC haplotypes identifies shuffling of segments in recent human history. PLoS Genet. 2:e9
119. Traherne JA, Martin M, Ward R, Ohashi M, Pellett F, et al. 2010. Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex. Hum. Mol. Genet. 19:737-51
120. Trowsdale J. 2001. Genetic and functional relationships betweenMHCandNKreceptor genes. Immunity 15:363-74
121. Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, et al. 2005. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat. Genet. 37:357-64
122. Vandiedonck C, Knight JC. 2009. The human Major Histocompatibility Complex as a paradigm in genomics research. Brief. Funct. Genomics Proteomics 8:379-94
123. Vandiedonck C, Taylor MS, Lockstone HE, Plant K, Taylor JM, et al. 2011. Pervasive haplotypic variation in the spliceo-Transcriptome of the human major histocompatibility complex. Genome Res. 21:1042-54
124. van Oosterhout C. 2009. A new theory of MHC evolution: Beyond selection on the immune genes. Proc. R. Soc. B 276:657-65
125. Vidal SM, Khakoo SI, Biron CA. 2011. Natural killer cell responses during viral infections: Flexibility and conditioning of innate immunity by experience. Curr. Opin. Virol. 1:497-512
126. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. 2008. Functions of natural killer cells. Nat. Immunol. 9:503-10
127. Walker BA, Hunt LG, Sowa AK, Skjodt K, Gobel TW, et al. 2011. The dominantly expressed class I molecule of the chicken MHC is explained by coevolution with the polymorphic peptide transporter (TAP) genes. Proc. Natl. Acad. Sci. USA 108:8396-401
128. Walsh EC, Mather KA, Schaffner SF, Farwell L, Daly MJ, et al. 2003. An integrated haplotype map of the human major histocompatibility complex. Am. J. Hum. Genet. 73:580-90
129. Wang C, Krishnakumar S, Wilhelmy J, Babrzadeh F, Stepanyan L, et al. 2012. High-Throughpu t, highfidelity HLA genotyping with deep sequencing. Proc. Natl. Acad. Sci. USA 109:8676-81
130. Wang F, Liu H, Blanton WP, Belkina A, Lebrasseur NK, Denis GV. 2010. Brd2 disruption in mice causes severe obesity without Type 2 diabetes. Biochem. J. 425:71-83
131. White PC, New MI, Dupont B. 1985. Molecular cloning of steroid 21-hydroxylase. Ann. N. Y. Acad. Sci. 458:277-87
132. Wills MR, Ashiru O, Reeves MB, Okecha G, Trowsdale J, et al. 2005. Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J. Immunol. 175:7457-65
133. Wong ES, Sanderson CE, Deakin JE, Whittington CM, Papenfuss AT, Belov K. 2009. Identification of natural killer cell receptor clusters in the platypus genome reveals an expansion of C-Type lectin genes. Immunogenetics 61:565-79
134. Wooldridge L, Ekeruche-Makinde J, Van Den Berg HA, Skowera A, Miles JJ, et al. 2011. A single autoimmune T cell receptor recognizes more than a million different peptides. J. Biol. Chem. 287:1168-77
135. Yang Y, Chung EK, Zhou B, Lhotta K, Hebert LA, et al. 2004. The intricate role of complement component C4 in human systemic lupus erythematosus. Curr. Dir. Autoimmun. 7:98-132
136. Yunis EJ, Larsen CE, Fernandez-Vina M, Awdeh ZL, Romero T, et al. 2003. Inheritable variable sizes of DNA stretches in the human MHC: Conserved extended haplotypes and their fragments or blocks. Tissue Antigens 62:1-20